









Markets
/
Stocks
/
nasdaq-glue
/

Monte Rosa Therapeutics Inc

GLUE

4.880USD

+0.090+1.88%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

300.17MMarket Cap

48.78P/E TTM



Monte Rosa Therapeutics Inc

4.880

+0.090+1.88%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

7882.05%84.93M

--60.65M

--9.22M

--4.70M

--1.06M

----

Revenue

7882.05%84.93M

--60.65M

--9.22M

--4.70M

--1.06M

----

Operating expenses

13.56%40.89M

36.66%47.64M

-3.31%35.74M

0.31%37.34M

5.11%36.01M

7.31%34.86M

30.34%36.97M

36.69%37.22M

40.97%34.26M

38.92%32.49M

42.75%28.36M

50.26%27.23M

111.25%24.30M

95.94%23.39M

211.12%19.87M

235.86%18.12M

167.97%11.50M

--11.94M

--6.39M

--5.40M

--4.29M

R&D expenses

19.11%32.19M

43.23%38.87M

-2.44%27.62M

-3.51%28.05M

1.01%27.03M

9.12%27.14M

32.63%28.31M

38.88%29.08M

49.34%26.75M

37.16%24.87M

41.20%21.34M

43.03%20.94M

93.20%17.91M

83.82%18.13M

176.22%15.12M

201.48%14.64M

143.07%9.27M

--9.86M

--5.47M

--4.86M

--3.81M

Depreciation, depletion, and amortization

7.79%2.05M

11.65%2.06M

14.67%2.10M

48.09%2.06M

58.33%1.90M

72.52%1.85M

77.54%1.83M

56.47%1.39M

59.36%1.20M

32.26%1.07M

77.49%1.03M

90.36%889.00K

174.82%753.00K

262.78%809.00K

240.35%582.00K

548.61%467.00K

285.92%274.00K

--223.00K

--171.00K

--72.00K

--71.00K

Other operating expenses

----

---6.03M

---5.32M

----

Operating profit

226.01%44.04M

137.30%13.00M

28.24%-26.53M

12.30%-32.64M

-2.01%-34.95M

-7.31%-34.86M

-30.34%-36.97M

-36.69%-37.22M

-40.97%-34.26M

-38.92%-32.49M

-42.75%-28.36M

-50.26%-27.23M

-111.25%-24.30M

-95.94%-23.39M

-211.12%-19.87M

-235.86%-18.12M

-167.97%-11.50M

---11.94M

---6.39M

---5.40M

---4.29M

Net non-operating interest income (expenses)

Non-operating interest income

40.83%3.44M

9.59%2.59M

29.86%2.89M

14.55%2.64M

0.21%2.44M

18.99%2.37M

123.37%2.23M

266.56%2.30M

1535.57%2.44M

--1.99M

--997.00K

--628.00K

--149.00K

----

Gains from sale of securities

-72.10%173.00K

100.26%2.00K

-666.67%-153.00K

43.01%-53.00K

387.04%620.00K

-175.27%-779.00K

-57.14%27.00K

-169.40%-93.00K

-325.00%-216.00K

-328.79%-283.00K

250.00%63.00K

145.27%134.00K

-47.25%96.00K

-34.69%-66.00K

110.34%18.00K

-1054.84%-296.00K

3133.33%182.00K

---49.00K

---174.00K

--31.00K

---6.00K

Special income (expenses)

----

--0.00

100.00%0.00

--0.00

---960.00K

---7.68M

--0.00

- Gains from disposal of fixed assets

--59.00K

--0.00

-100.00%0.00

----

--0.00

100.00%0.00

--24.00K

-100.00%0.00

--0.00

---16.00K

--0.00

--125.00K

----

Income before tax

249.62%47.71M

146.89%15.60M

31.47%-23.79M

14.09%-30.06M

0.48%-31.89M

-8.10%-33.27M

-27.07%-34.71M

-32.18%-34.99M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Income tax

890.36%822.00K

9936.36%2.16M

-58.24%71.00K

32.63%252.00K

--83.00K

---22.00K

--170.00K

--190.00K

----

Income after tax

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Net income from continuous operations

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Net income attributable to controlling interests

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Net income attributable to common shareholders

246.66%46.88M

140.41%13.44M

31.60%-23.86M

13.84%-30.31M

0.22%-31.97M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

-94.95%-23.93M

-19.25%-23.44M

-202.49%-19.84M

-243.12%-18.41M

-185.36%-12.28M

---19.66M

---6.56M

---5.36M

---4.30M

Basic earnings per share

207.40%0.57

128.04%0.16

58.46%-0.29

40.21%-0.43

18.15%-0.53

7.29%-0.58

-19.79%-0.70

-25.47%-0.71

-26.41%-0.65

-24.94%-0.63

-35.52%-0.58

-38.75%-0.57

-86.14%-0.51

-14.01%-0.50

-192.64%-0.43

-239.03%-0.41

-185.35%-0.28

---0.44

---0.15

---0.12

---0.10

Diluted earnings per share

206.35%0.57

128.04%0.16

58.46%-0.29

40.21%-0.43

18.15%-0.53

7.29%-0.58

-19.79%-0.70

-25.47%-0.71

-26.41%-0.65

-24.94%-0.63

-35.52%-0.58

-38.75%-0.57

-86.14%-0.51

-14.01%-0.50

-192.64%-0.43

-239.03%-0.41

-185.35%-0.28

---0.44

---0.15

---0.12

---0.10

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

